SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006459
Filing Date
2024-05-02
Accepted
2024-05-02 08:30:20
Documents
16
Period of Report
2024-05-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20240501x8k.htm   iXBRL 8-K 71119
2 EX-3.1 glyc-20240501xex3d1.htm EX-3.1 12545
3 EX-3.2 glyc-20240501xex3d2.htm EX-3.2 14383
  Complete submission text file 0001558370-24-006459.txt   320499

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20240501.xsd EX-101.SCH 3800
5 EX-101.LAB glyc-20240501_lab.xml EX-101.LAB 1355
6 EX-101.PRE glyc-20240501_pre.xml EX-101.PRE 11213
19 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240501x8k_htm.xml XML 4798
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 24905479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)